CNTA - Company ID 0001847903
Centessa Pharmaceuticals plc has filed 576 public company documents between 2021 and 2026. The most frequent type is insider trade (261 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 3y ago2023-04-04 | 2023-03-31 | View filing |
| 4 | Insider trade | 3y ago2023-04-04 | 2023-03-31 | View filing |
| 4 | Insider trade | 3y ago2023-04-04 | 2023-03-31 | View filing |
| 4 | Insider trade | 3y ago2023-04-04 | 2023-03-31 | View filing |
| 4 | Insider trade | 3y ago2023-04-04 | 2023-03-31 | View filing |
| 144 | Insider sale notice | 3y ago2023-04-03 | - | View filing |
| 10-K | Annual report | 3y ago2023-03-30 | 2022-12-31 | View filing |
| 8-K | Major company event | 3y ago2023-03-30 | 2023-03-30 | View filing |
| S-8 | Employee stock plan | 3y ago2023-03-30 | - | View filing |
| 4 | Insider trade | 3y ago2023-03-03 | 2023-03-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| 4 | Insider trade | 3y ago2023-02-03 | 2023-02-01 | View filing |
| SC 13G/A | Passive ownership stake (update) | 3y ago2023-01-31 | - | View filing |
| 8-K | Major company event | 3y ago2023-01-27 | 2023-01-27 | View filing |
| 424B5 | Prospectus supplement | 3y ago2023-01-27 | - | View filing |
| 8-K | Major company event | 3y ago2023-01-26 | 2023-01-26 | View filing |
| 4 | Insider trade | 3y ago2023-01-13 | 2022-09-30 | View filing |
| 4 | Insider trade | 3y ago2023-01-13 | 2022-09-30 | View filing |
| 4 | Insider trade | 3y ago2023-01-13 | 2022-09-30 | View filing |
| 4 | Insider trade | 3y ago2023-01-13 | 2022-09-30 | View filing |
| 4 | Insider trade | 3y ago2023-01-13 | 2022-09-30 | View filing |
| 4 | Insider trade | 3y ago2023-01-13 | 2022-09-30 | View filing |
| 4 | Insider trade | 3y ago2023-01-13 | 2022-09-30 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |
| 4 | Insider trade | 3y ago2023-01-04 | 2022-12-31 | View filing |